Phase 3 N=10 Intratympanic Steroid for Bell's Palsy
Bell's Palsy · Facial Nerve Paresis
Primary: Facial Nerve Recovery — 7; 81.56 Days
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=97 Self-guided Psychosocial Intervention for Facial Palsy
Facial Palsy
Primary: FACE-Q Psychological Function — 38.19 units on a scale
N/A N=14 Study of a New Technique to Improve the Symptoms of Orofacial Discomfort in Patients With Peripheral Facial Paralysis
Peripheral Nerve Facial Nerve Paralysis · Facial Nerve Diseases · Orofacial Pain
Primary: The Visual Analog Scale for Pain Was Used to Grade Discomfort in Chewing After the Installation of Facial Paralysis. Level Zero is the Lack of Discomfort and 10 is the…
Phase 4 N=15 Mixed Methods Investigation of Chronic Facial Paralysis in Individuals With Synkinesis
Synkinesis
Primary: Change in Sunnybrook Facial Grading System (SFGS) Between Baseline and 4 Month Scoring — 0.29; 5.86 score on a scale
Phase 4 N=30 Effect of a Transcutaneous Electrical Nerve Stimulation (TENS) Device on Overall Facial Appearance
Ageing
Primary: Evaluate Overall Facial Improvement Assessed Live by the Investigator and Subjects Using the Global Aesthetic Improvement Scale (GAIS) at 12 Weeks Compared to Baseline…
Phase 4 N=60 Ultrasound Guided Trigeminal Nerve Block for Typical or Atypical Facial Pain
Typical Facial Pain · Atypical Facial Pain
Primary: The Proportion of Subjects Reporting at Least 50% Overall Pain Relief — 19; 14; 10; 16 Participants — p=.196
N/A N=19 Clinical Trial to Improve the Magnetic Levator Prosthesis
Blepharoptosis · Ptosis, Eyelid · Myasthenia Gravis
Primary: Change in Interpalpebral Fissure During Eye Opening — 4.5; 6.9; 6.2; 6.3 millimeters — p=>=0.46
N/A N=22 Combined Brain and Peripheral Nerve Stimulation for Stroke
Stroke
Primary: Active Range of Motion of Wrist Extension in the Paretic Side — 37.8; 38; 37.2; 38 degrees
N/A N=11 Magnetic Correction of Eye Lid Paralysis
Blepharoptosis · Lagophthalmos · Facial Paralysis
Primary: Rating Scale of Skin Integrity — 0.3 units on a scale
N/A N=116 Peripheral Nerve Stimulation(PNS) for Subacromial Impingement Syndrome(SIS)
Shoulder Pain · Shoulder Impingement Syndrome · Shoulder Tendinitis
Primary: Change in - Short Form (SF) Question 3 (BPI-SF3) — 6.90; 7.05; 3.58; 3.96 units on a scale
Phase 2 N=20 Functional Electrical Stimulation in Irradiated Nasopharyngeal Carcinoma (NPC)
Dysphagia
Primary: The Change From Baseline and Cut Point VFSS in Velocity of Displacement of Hyoid Bone at 1 to 3 Months — 0.8; -0.4 cm/s
N/A N=19 MRI Diffusion Tensor Tractography to Monitor Peripheral Nerve Recovery After Severe Crush or Cut/Repair Nerve Injury
Nerve Injury
Primary: Michigan Hand Questionnaire (MHQ) in TPNI Subjects Post Surgery — 33; 83; 5; 75 score on a scale
Phase 2 N=42 Masked Faces in Parkinson Disease: Mechanism and Treatment
Parkinson's Disease
Primary: Change in Facial Entropy Score From Baseline [Off Dopamine Medication] — 5.649; -1.605 units on a scale — p=< 0.001
N/A N=24 Noninvasive Vagus Nerve Stimulation (VNS) for Neuromotor Adaptations
Healthy Young Adults
Primary: Visuomotor Skill — 1; 1; 0.870; 0.969 Ratio of the baseline value — p=0.0096
Phase 2 N=27 Bevonescein to Highlight Nerves in Patients Undergoing Head & Neck Surgery
Parotid Neoplasm · Thyroid Neoplasms · Head and Neck Neoplasms
Primary: Safety - The Number of Patients With ALM-488 Related Adverse Events — 0; 0; 0; 0 Participants
N/A N=36 Enhancing Plasticity in Stroke Patients With Severe Motor Deficit
Stroke · Cerebrovascular Accident
Primary: Change in Fugl Meyer Assessment Motor Score — 7.4; 3.4; 7.2; 2.8 units on a scale
N/A N=23 Peripheral Nerve Stimulation for Shoulder Pain: Dose Response
Stroke · Shoulder Pain
Primary: Brief Pain Inventory (BPI)- Short Form (SF) Question 3 (BPI-SF3) — 5.6; 6; 5.67; 6.5 score on a scale
N/A N=20 NMES Efficacy on Patients With NBPP
Neonatal Brachial Plexus Palsy
Primary: Change From Baseline in Upper Extremity Muscle Strength — 1; 1 score on a scale — p=0.40
N/A N=28 Geometrical Facial Deformation According to Posture in Amyotrophic Lateral Sclerosis
Amyotrophic Lateral Sclerosis
Primary: The Amounts of Change of Landmarks Position According to Posture — 1.0; 2.4; 2.9; 5.6 mm
Phase 4 N=71 Comparison of Three Botulinum Neuromodulators for Management of Facial Synkinesis
Facial Nerve Injuries · Facial Paresis Associated With Facial Nerve Dysfunction · Facial Asymmetry
Primary: Change in Synkinesis Assessment Questionnaire (SAQ) Scores — 45.9; 38.8; 51.3; 45.2 units on a scale
N/A N=40 High-Purity Type I Collagen Nerve Wrapping in Peripheral Nerve Procedures: A Prospective Registry
Peripheral Nerve Injuries · Neuroma of Nerve Repair · Nerve Graft; Complications, Mechanical
Primary: Motor Functional Recovery (MRC Grade ≥ M3) — 34 Participants
N/A N=29 Ultrasound-guided Intermediate Cervical Plexus Block
Internal Carotid Artery Stenosis
Primary: Local Anesthetic Supplementation (Frequency) — 11; 7 participants — p=0.236
Phase 2 N=50 External Trigeminal Nerve Stimulation for Epilepsy
Epilepsy · Seizure Disorders
Primary: 50% Responder Rate — 40.5; 15.6 percentage of participants
N/A N=112 Peripheral Nerve Stimulation Registry for Intractable Migraine Headache
Intractable Chronic Migraine
Primary: Adverse Events (First 12 Weeks) — 17; 27; 5; 1 events
Phase 4 N=30 Emervel for the Correction of Lower Face Wrinkles & Folds
Nasolabial Folds · Marionette Lines · Wrinkles
Primary: Number of Subjects With Naturalness of Expression in Motion (2D Video) — 30 Participants
N/A N=9 Transcranial Magnetic Stimulation for Facial Pain
Trigeminal Nerve Injuries · Post-herpetic Neuralgia · Facial Pain
Primary: Visual Analogue Scale (VAS) — 5.4 score on a scale
Phase 2 N=8 Identification of Nerves Using Fluorescein Sodium
Pleomorphic Adenoma of the Parotid · Warthin Tumor · Head and Neck Disorder
Primary: Facial Nerve Correlation of Fluorescein Sodium With Electrostimulation — 3.8 score on a scale
N/A N=7 Percutaneous Peripheral Nerve Stimulation (Neuromodulation) for Postoperative Analgesia
Postoperative Pain
Primary: Change From Baseline of Surgical Site Pain Level (NRS) at Rest [Percentage of Baseline Pain] — 64; 100; 55; 69 percentage of baseline
Phase 3 N=220 Comparison of Processed Nerve Allograft and Collagen Nerve Cuffs for Peripheral Nerve Repair
Peripheral Nerve Discontinuities
Primary: Static Two-Point Discrimination (Pre-defined Mixed Modeling Approach) — 9.1; 9.3 Millimeters
N/A N=9 Repair of Infective Wound Associated With Nerve Defect in the Finger Using A Bipedicled Nerve Flap
Infection Wound · Disruption of Nerve Repair
Primary: 2-point Discrimination Test — 7.5 mm